Microglia as Therapeutic Target for Radiation-Induced Brain Injury

Int J Mol Sci. 2022 Jul 27;23(15):8286. doi: 10.3390/ijms23158286.

Abstract

Radiation-induced brain injury (RIBI) after radiotherapy has become an increasingly important factor affecting the prognosis of patients with head and neck tumor. With the delivery of high doses of radiation to brain tissue, microglia rapidly transit to a pro-inflammatory phenotype, upregulate phagocytic machinery, and reduce the release of neurotrophic factors. Persistently activated microglia mediate the progression of chronic neuroinflammation, which may inhibit brain neurogenesis leading to the occurrence of neurocognitive disorders at the advanced stage of RIBI. Fully understanding the microglial pathophysiology and cellular and molecular mechanisms after irradiation may facilitate the development of novel therapy by targeting microglia to prevent RIBI and subsequent neurological and neuropsychiatric disorders.

Keywords: brain injury; cognitive effects; ionizing radiation; microglia; therapy.

Publication types

  • Review

MeSH terms

  • Brain / pathology
  • Brain Injuries* / pathology
  • Humans
  • Microglia / pathology
  • Neurogenesis / radiation effects
  • Radiation Injuries* / etiology
  • Radiation Injuries* / pathology